Antibiotics Market in Europe would register a CAGR of 4.9% during 2020-2026

Published Date: 5-Feb-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Europe Antibiotics Market, published by KBV research, the Europe Antibiotics Market would witness market growth of 4.9% CAGR during the forecast period (2020-2026).

The Germany market dominated the Europe Antibiotics Market by Country in 2019, growing at a CAGR of 4.2 % during the forecast period. The UK market is exhibiting a CAGR of 3.9% during (2020 - 2026). Additionally, The France market is poised to grow at a CAGR of 6.2% during (2020 - 2026).

The Cephalosporin market dominated the Russia Antibiotics Market by Drug Class in 2019, growing at a CAGR of 3.9 % during the forecast period. The Penicillin market is estimated to grow at a CAGR of 3.8% during (2020 - 2026). The Fluoroquinolone market is witnessing a CAGR of 6.6% during (2020 - 2026). Additionally, The Macrolides market is expected to witness highest CAGR of 6.7% during (2020 - 2026).

The Cell Wall Synthesis Inhibitors market dominated the Italy Antibiotics Market by Action Mechanism in 2019, thereby, achieving a market value of $314.3 million by 2026. The Protein Synthesis Inhibitors market is experiencing a CAGR of 4.2% during (2020 - 2026). Additionally, The Mycolic Acid Inhibitors market would showcase highest CAGR of 6.9% during (2020 - 2026).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.

Europe Antibiotics Market Segmentation

By Action Mechanism

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors,
  • Mycolic Acid Inhibitors

By Drug Class

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides,
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Antibiotics Market Related Reports:

Global Market

North America Market

Asia Pacific Market

LAMEA Market

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.